BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29868949)

  • 1. Encapsulation of Exogenous Proteins in Vault Nanoparticles.
    Wang M; Abad D; Kickhoefer VA; Rome LH; Mahendra S
    Methods Mol Biol; 2018; 1798():25-37. PubMed ID: 29868949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vault Nanoparticles Packaged with Enzymes as an Efficient Pollutant Biodegradation Technology.
    Wang M; Abad D; Kickhoefer VA; Rome LH; Mahendra S
    ACS Nano; 2015 Nov; 9(11):10931-40. PubMed ID: 26493711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and assembly of human vault particles in yeast.
    Wang M; Kickhoefer VA; Rome LH; Foellmer OK; Mahendra S
    Biotechnol Bioeng; 2018 Dec; 115(12):2941-2950. PubMed ID: 30171681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilization of recombinant vault nanoparticles on solid substrates.
    Xia Y; Ramgopal Y; Li H; Shang L; Srinivas P; Kickhoefer VA; Rome LH; Preiser PR; Boey F; Zhang H; Venkatraman SS
    ACS Nano; 2010 Mar; 4(3):1417-24. PubMed ID: 20146454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
    Mikyas Y; Makabi M; Raval-Fernandes S; Harrington L; Kickhoefer VA; Rome LH; Stewart PL
    J Mol Biol; 2004 Nov; 344(1):91-105. PubMed ID: 15504404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior.
    Poderycki MJ; Kickhoefer VA; Kaddis CS; Raval-Fernandes S; Johansson E; Zink JI; Loo JA; Rome LH
    Biochemistry; 2006 Oct; 45(39):12184-93. PubMed ID: 17002318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution Structures of Engineered Vault Particles.
    Ding K; Zhang X; Mrazek J; Kickhoefer VA; Lai M; Ng HL; Yang OO; Rome LH; Zhou ZH
    Structure; 2018 Apr; 26(4):619-626.e3. PubMed ID: 29551289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of vault-like particles in insect cells expressing only the major vault protein.
    Stephen AG; Raval-Fernandes S; Huynh T; Torres M; Kickhoefer VA; Rome LH
    J Biol Chem; 2001 Jun; 276(26):23217-20. PubMed ID: 11349122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sea urchin vault structure, composition, and differential localization during development.
    Stewart PL; Makabi M; Lang J; Dickey-Sims C; Robertson AJ; Coffman JA; Suprenant KA
    BMC Dev Biol; 2005 Feb; 5():3. PubMed ID: 15710043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of vault nanocapsules with enzymatic and fluorescent properties.
    Kickhoefer VA; Garcia Y; Mikyas Y; Johansson E; Zhou JC; Raval-Fernandes S; Minoofar P; Zink JI; Dunn B; Stewart PL; Rome LH
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4348-52. PubMed ID: 15753293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the Vault Protein-Protein Interaction for Tuning of Molecular Release.
    Yu K; Yau YH; Sinha A; Tan T; Kickhoefer VA; Rome LH; Lee H; Shochat SG; Lim S
    Sci Rep; 2017 Nov; 7(1):14816. PubMed ID: 29093465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural stability of vault particles.
    Esfandiary R; Kickhoefer VA; Rome LH; Joshi SB; Middaugh CR
    J Pharm Sci; 2009 Apr; 98(4):1376-86. PubMed ID: 18683860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the vault particle as a platform technology.
    Rome LH; Kickhoefer VA
    ACS Nano; 2013 Feb; 7(2):889-902. PubMed ID: 23267674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vault ribonucleoprotein particle exhibiting 39-fold dihedral symmetry.
    Kato K; Tanaka H; Sumizawa T; Yoshimura M; Yamashita E; Iwasaki K; Tsukihara T
    Acta Crystallogr D Biol Crystallogr; 2008 May; 64(Pt 5):525-31. PubMed ID: 18453688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaults: a ribonucleoprotein particle involved in drug resistance?
    Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
    Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptake.
    Galbiati E; Avvakumova S; La Rocca A; Pozzi M; Messali S; Magnaghi P; Colombo M; Prosperi D; Tortora P
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2254-2260. PubMed ID: 30036602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
    van Zon A; Mossink MH; Schoester M; Houtsmuller AB; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
    J Cell Sci; 2003 Nov; 116(Pt 21):4391-400. PubMed ID: 13130096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.
    Yang J; Kickhoefer VA; Ng BC; Gopal A; Bentolila LA; John S; Tolbert SH; Rome LH
    ACS Nano; 2010 Dec; 4(12):7229-40. PubMed ID: 21121616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
    Zheng CL; Sumizawa T; Che XF; Tsuyama S; Furukawa T; Haraguchi M; Gao H; Gotanda T; Jueng HC; Murata F; Akiyama S
    Biochem Biophys Res Commun; 2005 Jan; 326(1):100-7. PubMed ID: 15567158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Draft crystal structure of the vault shell at 9-A resolution.
    Anderson DH; Kickhoefer VA; Sievers SA; Rome LH; Eisenberg D
    PLoS Biol; 2007 Nov; 5(11):e318. PubMed ID: 18044992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.